Coming Soon ...

Indications :

Collagenase SANTYL Ointment (“SANTYL”) is indicated for debriding chronic dermal ulcers and severely burned areas.

Contraindications: SANTYL is contraindicated in patients who have shown local or systemic hypersensitivity to collagenase.

Warnings and Precautions: The optimal pH range of collagenase is 6 to 8. Higher or lower pH conditions will decrease the enzyme’s activity and appropriate precautions should be taken. The enzymatic activity is also adversely affected by certain detergents, and heavy metal ions such as mercury and silver which are used in some antiseptics. As such, the wound should be properly cleansed prior to application of SANTYL. Debilitated patients should be closely monitored for systemic bacterial infections because of the theoretical possibility that debriding enzymes may increase the risk of bacteremia. A slight transient erythema has been noted occasionally in the surrounding tissue, particularly when SANTYL was not confined to the wound. SANTYL is not indicated for wound closure. Discontinue use of SANTYL after granulation tissue is well-established.

Adverse Reactions: No allergic sensitivity or toxic reactions have been noted in clinical use when used as directed. The risk information provided herein is not comprehensive. To see the complete Prescribing Information, please see the FDA-approved product labeling, here: You are encouraged to report negative side effects of prescription drugs to the FDA. Visit MedWatch or call 1-800-FDA-1088.

Click here for full Prescribing Information.

VERSAJET Ⅱ Hydrosurgery System: Click here for Instructions of Use

OASIS® Matrix: Click here for Instructions of Use

Indications :

Collagenase SANTYL Ointment (“SANTYL”) is indicated for debriding chronic dermal ulcers and severely burned areas.

Contraindications: SANTYL is contraindicated in patients who have shown local or systemic hypersensitivity to collagenase.

Warnings and Precautions: The optimal pH range of collagenase is 6 to 8. Higher or lower pH conditions will decrease the enzyme’s activity and appropriate precautions should be taken. The enzymatic activity is also adversely affected by certain detergents, and heavy metal ions such as mercury and silver which are used in some antiseptics. As such, the wound should be properly cleansed prior to application of SANTYL. Debilitated patients should be closely monitored for systemic bacterial infections because of the theoretical possibility that debriding enzymes may increase the risk of bacteremia. A slight transient erythema has been noted occasionally in the surrounding tissue, particularly when SANTYL was not confined to the wound. SANTYL is not indicated for wound closure. Discontinue use of SANTYL after granulation tissue is well-established.

Adverse Reactions: No allergic sensitivity or toxic reactions have been noted in clinical use when used as directed. The risk information provided herein is not comprehensive. To see the complete Prescribing Information, please see the FDA-approved product labeling, here: You are encouraged to report negative side effects of prescription drugs to the FDA. Visit MedWatch or call 1-800-FDA-1088.

Click here for full Prescribing Information.

VERSAJET Ⅱ Hydrosurgery System: Click here for Instructions of Use

OASIS® Matrix: Click here for Instructions of Use

Coming Soon ...

WEBINAR #1 - SANTYL
WEBINAR #1 - SANTY
WEBINAR #2 - VERSAJET
WEBINAR #2 - VERSAJET
Indications :

Collagenase SANTYL Ointment (“SANTYL”) is indicated for debriding chronic dermal ulcers and severely burned areas.

Contraindications: SANTYL is contraindicated in patients who have shown local or systemic hypersensitivity to collagenase.

Warnings and Precautions: The optimal pH range of collagenase is 6 to 8. Higher or lower pH conditions will decrease the enzyme’s activity and appropriate precautions should be taken. The enzymatic activity is also adversely affected by certain detergents, and heavy metal ions such as mercury and silver which are used in some antiseptics. As such, the wound should be properly cleansed prior to application of SANTYL. Debilitated patients should be closely monitored for systemic bacterial infections because of the theoretical possibility that debriding enzymes may increase the risk of bacteremia. A slight transient erythema has been noted occasionally in the surrounding tissue, particularly when SANTYL was not confined to the wound. SANTYL is not indicated for wound closure. Discontinue use of SANTYL after granulation tissue is well-established.

Adverse Reactions: No allergic sensitivity or toxic reactions have been noted in clinical use when used as directed. The risk information provided herein is not comprehensive. To see the complete Prescribing Information, please see the FDA-approved product labeling, here: You are encouraged to report negative side effects of prescription drugs to the FDA. Visit MedWatch or call 1-800-FDA-1088.

Click here for full Prescribing Information.

VERSAJET Ⅱ Hydrosurgery System: Click here for Instructions of Use

OASIS® Matrix: Click here for Instructions of Use

About the Speakers
DAVID G'SELL_ HEADSHOT
DEB BOORSE,
MSN, RN, CRNP

Deb Boorse is a Nurse Practitioner with over 40 years experience in burn and trauma and is currently at the Lehigh Valley Health Network in Allentown, Pennsylvania.

DEB BOORSE_HEADSHOT
David G’Sell,
PA-C

DJ G’Sell is a Physician Assistant in the Burn Unit at University Medical Center New Orleans which is an ACS Level 1 Trauma Center and ABA Verified Burn Center.

DAVID G'SELL_ HEADSHOT
DEB BOORSE,
MSN, RN, CRNP

Deb Boorse is a Nurse Practitioner with over 40 years experience in burn and trauma and is currently at the Lehigh Valley Health Network in Allentown, Pennsylvania.

DEB BOORSE_HEADSHOT
David G’Sell,
PA-C

DJ G’Sell is a Physician Assistant in the Burn Unit at University Medical Center New Orleans which is an ACS Level 1 Trauma Center and ABA Verified Burn Center.

ROBERT HAFNER_HEADSHOT
Robert Hafner,
ACNP-C

Robert 'Bob' Hafner has been an Acute Care and Family Practice Nurse Practitioner at the Grossman Burn Center in Kansas City, MO since it opened in 2013.

  • WEBINAR #1 - SANTYL
    DEB BOORSE_HEADSHOT
    DEB BOORSE,
    MSN, RN, CRNP

    Deb Boorse is a Nurse Practitioner with over 40 years experience in burn and trauma and is currently at the Lehigh Valley Health Network in Allentown, Pennsylvania.

  • WEBINAR #2 - VERSAJET
    ROBERT HAFNER_HEADSHOT
    David G’Sell,
    PA-C

    DJ G’Sell is a Physician Assistant in the Burn Unit at University Medical Center New Orleans which is an ACS Level 1 Trauma Center and ABA Verified Burn Center.